A public resource of baseline data from the Alzheimer’s Prevention Initiative Autosomal-Dominant Alzheimer’s Disease Trial

ABSTRACT: Introduction: The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease (API ADAD) Trial evaluated the anti-oligomeric amyloid beta (Aβ) antibody therapy crenezumab in cognitively unimpaired members of the Colombian presenilin 1 (PSEN1) E280A kindred. We report...

Full description

Autores:

Ríos Romenets, Silvia
Giraldo Chica, Margarita María
Acosta Baena, Natalia
Tobón Quintero, Carlos Andrés
Lopera Restrepo, Francisco Javier
Reiman, Eric M.
Brown, Chris
Hu, Nan
Chen, Yinghua
Ghisays, Valentina
Enos, Jéssica
Goradia, Dhruman D.
Lee, Wendy
Luo, Ji
Malek Ahmadi, Michael
Protas, Hillary
Thomas, Ronald G.
Chen, Kewei
Boker, Connie
Su, Yi
Mastroeni, Diego
Álvarez, Sergio
Quiroz, Yakeel T.
Langbaum, Jéssica B.
Sink, Kaycee M.
Pruzin, Jeremy J.
Tairot, Pierre N.

Tipo de recurso:

Article of investigation

Fecha de publicación:

2023

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/39088

Acceso en línea:

https://hdl.handle.net/10495/39088

Palabra clave:

Enfermedad de Alzheimer
Alzheimer Disease
Péptidos beta-Amiloides
Amyloid beta-Peptides
Tomografía de Emisión de Positrones
Positron-Emission Tomography
https://id.nlm.nih.gov/mesh/D000544
https://id.nlm.nih.gov/mesh/D016229
https://id.nlm.nih.gov/mesh/D049268

Rights

openAccess

License

https://creativecommons.org/licenses/by-nc/4.0/